[Doxapram: a new analeptic in the isolated and associated therapy of cardiorespiratory insufficiency in medical practice].
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004315:Doxapram / Q000627:therapeutic use; D006330:Heart Defects, Congenital / Q000188:drug therapy; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D006349:Heart Valve Diseases / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D010845:Obesity Hypoventilation Syndrome / Q000188:drug therapy; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D011760:Pyrrolidinones / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D013328:Strophanthins / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D004071:Digitalis Glycosides; D009025:Morpholines; D011760:Pyrrolidinones; D013328:Strophanthins; D004315:Doxapram
Il doxapram: un nuovo analettico nella terapia isolata ed associata delle insufficienze cardiorespiratorie nella pratica medica.